KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Treasury Shares: 2017-2024

Historic Treasury Shares for TherapeuticsMD (TXMD) over the last 8 years, with Dec 2024 value amounting to $5,000.

  • TherapeuticsMD's Treasury Shares rose 13057.89% to $5,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $5,000, marking a year-over-year increase of 13057.89%. This contributed to the annual value of $5,000 for FY2024, which is 87.50% down from last year.
  • Latest data reveals that TherapeuticsMD reported Treasury Shares of $5,000 as of FY2024, which was down 87.50% from $40,000 recorded in FY2023.
  • TherapeuticsMD's 5-year Treasury Shares high stood at $141,000 for FY2020, and its period low was $272 during FY2021.
  • Its 3-year average for Treasury Shares is $34,000, with a median of $40,000 in 2023.
  • Per our database at Business Quant, TherapeuticsMD's Treasury Shares slumped by 99.81% in 2021 and then spiked by 20,855.88% in 2022.
  • Over the past 5 years, TherapeuticsMD's Treasury Shares (Yearly) stood at $141,000 in 2020, then slumped by 99.81% to $272 in 2021, then surged by 20,855.88% to $57,000 in 2022, then fell by 29.82% to $40,000 in 2023, then tumbled by 87.50% to $5,000 in 2024.